Stevin Zorn, Ph.D.

President, CEO, and Co-Founder of MindImmune Therapeutics, Inc.

Professional Overview

Stevin Zorn, Ph.D., is a distinguished leader in the biopharmaceutical industry with over 30 years of experience in drug discovery and development, particularly in the fields of neuroscience and neuroinflammation. As the President, CEO, and Co-Founder of MindImmune Therapeutics, Inc., he spearheads the company's mission to develop innovative therapeutics that address unmet needs in the treatment of central nervous system (CNS) disorders.

Current Role

As President, CEO, and Co-Founder of MindImmune Therapeutics, Inc., Dr. Zorn is responsible for driving the company's strategic vision, overseeing research and development initiatives, and fostering collaborative partnerships to accelerate the advancement of its novel drug candidates. Under his leadership, MindImmune has secured significant funding and made significant progress in its pipeline of CNS-focused therapies.

Career Progression

Prior to his current roles, Dr. Zorn held several influential positions at leading pharmaceutical companies, including Pfizer and Lundbeck. At Pfizer, he served as the Vice President of Global Neuroscience Research and the Therapeutic Area Head, where he played a pivotal role in advancing the company's neuroscience pipeline. During his tenure at Lundbeck, he served as the Executive Vice President of Neuroscience and Neuroinflammation, leveraging his extensive expertise to drive the development of groundbreaking therapies.

Academic Background

Dr. Zorn holds a Ph.D. in Molecular and Cellular Neuroscience from Rockefeller University, where he conducted post-doctoral research. His academic credentials also include an Adjunct Full Professorship of Biomedical and Pharmaceutical Sciences at the University of Rhode Island College of Pharmacy and a Ryan Research Professorship of Neuroscience at the George and Anne Ryan Institute of Neuroscience, University of Rhode Island.

Areas of Expertise

Throughout his distinguished career, Dr. Zorn has developed a deep expertise in drug discovery and development, with a particular focus on CNS disorders, neuroinflammation, and neurodegenerative diseases. He possesses strong leadership and management capabilities, having successfully led cross-functional teams and driven the advancement of numerous drug candidates from the preclinical stage to clinical trials.

Professional Impact

Dr. Zorn's contributions to the biopharmaceutical industry are widely recognized. He has authored numerous peer-reviewed publications and has been an invited speaker at prestigious scientific conferences. Additionally, he has served on advisory boards and scientific review panels, further demonstrating his distinguished reputation and impact within the field.

Conclusion

With his extensive experience, academic credentials, and proven track record of success, Dr. Stevin Zorn is a highly respected leader in the biopharmaceutical industry. As the President, CEO, and Co-Founder of MindImmune Therapeutics, Inc., he is poised to continue driving innovation and advancing groundbreaking therapies that have the potential to transform the lives of patients suffering from CNS disorders.